drugset / Trial / NCT07342296

Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38

NCT07342296

Not yet recruiting 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether PACAP-38 administration can trigger aura in individuals with a diagnosis of migraine with aura.

Timeline

Start
2026-02-01
Primary completion
2026-12-01
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject PACAP38 Peptide Intravenous

Indications